If you are filing a Marketing Authorization Application (MAA) in Europe, your dossier must reference the current version of 0478 (updated annually in April). The EDQM frequently revises 0478 to include new dosage forms like orodispersible films and mini-tablets.
: Manufacturers must ensure that tablets are robust enough to withstand handling while maintaining precise delivery of the active substance.